The Aim of the en-ABL e-registry is to evaluate safety and efficacy of ABLUMINUS DES (Sirolimus Eluting Stent) in diabetic patients vs. non diabetic patients. The en-ABL e-registry is a… Click to show full abstract
The Aim of the en-ABL e-registry is to evaluate safety and efficacy of ABLUMINUS DES (Sirolimus Eluting Stent) in diabetic patients vs. non diabetic patients. The en-ABL e-registry is a prospective, real world, all-comers, multicenter registry. Overall, 2500 patients have been enrolled. Among them
               
Click one of the above tabs to view related content.